NasdaqGM - Nasdaq Real Time Price USD

Avidity Biosciences, Inc. (RNA)

Compare
47.30 +0.25 (+0.53%)
At close: October 4 at 4:00 PM EDT
47.05 -0.25 (-0.53%)
After hours: October 4 at 7:26 PM EDT
Advanced Chart
Loading Chart for RNA
DELL
  • Previous Close 47.05
  • Open 47.85
  • Bid 47.24 x 100
  • Ask 47.34 x 400
  • Day's Range 47.08 - 48.61
  • 52 Week Range 4.82 - 49.41
  • Volume 765,301
  • Avg. Volume 1,447,731
  • Market Cap (intraday) 5.592B
  • Beta (5Y Monthly) 0.89
  • PE Ratio (TTM) --
  • EPS (TTM) -2.95
  • Earnings Date Nov 6, 2024 - Nov 11, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 66.09

Avidity Biosciences, Inc., a biopharmaceutical company, engages in the delivery of RNA therapeutics. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat diseases previously untreatable with RNA therapeutics. The company's lead product candidate AOC 1001 for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease that is in phase 1/2 clinical trial. Its other products in pipeline include AOC 1044 for the treatment of duchenne muscular dystrophy, which is under phase 1/2 clinical development trial; and AOC 1020 to treat facioscapulohumeral muscular dystrophy that is in phase 1/2 clinical trial. The company is developing products for rare skeletal muscle and rare cardiac diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

www.aviditybiosciences.com

253

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Avidity Biosciences, Inc.

Recent News: RNA

View More
View More

Performance Overview: RNA

Trailing total returns as of 10/4/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RNA
422.65%
S&P 500
20.57%

1-Year Return

RNA
656.80%
S&P 500
35.98%

3-Year Return

RNA
103.70%
S&P 500
31.99%

5-Year Return

RNA
78.49%
S&P 500
89.10%

Compare To: RNA

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

RNA
Avidity Biosciences, Inc.
47.30
+0.53%
Mkt Cap 5.592B
Industry Biotechnology
DYN
Dyne Therapeutics, Inc.
32.58
-2.89%
Mkt Cap 3.271B
Industry Biotechnology
SMMT
Summit Therapeutics Inc.
19.09
+2.58%
Mkt Cap 14.029B
Industry Biotechnology
EWTX
Edgewise Therapeutics, Inc.
28.40
+6.65%
Mkt Cap 2.663B
Industry Biotechnology
JANX
Janux Therapeutics, Inc.
45.02
+1.92%
Mkt Cap 2.348B
Industry Biotechnology
ADMA
ADMA Biologics, Inc.
20.29
+3.68%
Mkt Cap 4.729B
Industry Biotechnology
CNTA
Centessa Pharmaceuticals plc
15.94
+0.38%
Mkt Cap 2.049B
Industry Biotechnology
VERA
Vera Therapeutics, Inc.
40.84
+0.86%
Mkt Cap 2.239B
Industry Biotechnology
VRNA
Verona Pharma plc
32.01
+3.89%
Mkt Cap 2.6B
Industry Biotechnology
LBPH
Longboard Pharmaceuticals, Inc.
36.22
+0.47%
Mkt Cap 1.409B
Industry Biotechnology
VKTX
Viking Therapeutics, Inc.
64.96
+1.33%
Mkt Cap 7.197B
Industry Biotechnology

Statistics: RNA

View More

Valuation Measures

Annual
As of 10/4/2024

  • Market Cap

    5.59B

  • Enterprise Value

    4.30B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    384.19

  • Price/Book (mrq)

    4.58

  • Enterprise Value/Revenue

    405.80

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -18.20%

  • Return on Equity (ttm)

    -28.36%

  • Revenue (ttm)

    10.6M

  • Net Income Avi to Common (ttm)

    -252.45M

  • Diluted EPS (ttm)

    -2.95

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.3B

  • Total Debt/Equity (mrq)

    0.69%

  • Levered Free Cash Flow (ttm)

    -109.55M

View More

Research Analysis: RNA

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 2.04M
Earnings -70.79M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

51.00
66.09 Average
47.30 Current
96.00 High
 
View More

Company Insights: RNA

People Also Watch

RVMD Revolution Medicines, Inc.
47.32
+2.58%
 
PCVX Vaxcyte, Inc.
111.29
+0.19%
 
PLRX Pliant Therapeutics, Inc.
11.53
+3.69%
 
AKRO Akero Therapeutics, Inc.
28.24
+2.13%
 
STOK Stoke Therapeutics, Inc.
11.79
-0.17%
 
NKTX Nkarta, Inc.
3.9200
+0.51%
 
KYMR Kymera Therapeutics, Inc.
43.06
-0.81%
 
FDMT 4D Molecular Therapeutics, Inc.
9.97
-3.58%
 
BDTX Black Diamond Therapeutics, Inc.
3.7500
+2.46%
 
CABA Cabaletta Bio, Inc.
4.2600
-1.16%
 
RLAY Relay Therapeutics, Inc.
6.53
+0.62%
 
CRNX Crinetics Pharmaceuticals, Inc.
53.14
+0.70%
 
GBIO Generation Bio Co.
2.4800
+4.20%
 
ARQT Arcutis Biotherapeutics, Inc.
10.02
-1.52%
 
ALEC Alector, Inc.
4.6200
+9.48%
 
NRIX Nurix Therapeutics, Inc.
22.20
+2.45%